** Shares of drug and medical device maker Johnson & Johnson JNJ.N fall 1% to $152.75
** JNJ reports medical device sales of $8.02 billion for the quarter, which came in below analysts' estimates of $8.17 billion, as per LSEG data
** Sales of J&J's medical devices have missed Wall Street estimates for the past 4 quarters
** Co also flagged a $400 million impact from tariffs, mostly related to tariffs already in place for China and Mexico that could hurt its medical device business
** "We would caution that JNJ has some of the highest China exposure (~10%) in MedTech," said JP Morgan analysts
** Overall, JNJ reported Q1 profit and revenue above analysts' expectations
** As of last close, JNJ stock up 6.7% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))